Abbott’s €440M Kilkenny facility is now the global hub for FreeStyle Libre 3 sensor production.

Abbott has officially opened a state-of-the-art manufacturing facility in Kilkenny, Ireland. This new site is dedicated to producing FreeStyle Libre 3 sensors, advancing care for people living with diabetes.

Here are some key highlights:
🔹The 30,000-square-meter facility is part of a €440 million investment in Ireland, creating more than 800 jobs in Kilkenny and an additional 200 roles in Donegal.
🔹This is now the global center of excellence for Abbott’s diabetes care manufacturing, producing FreeStyle Libre 3 sensors.
🔹 The facility incorporates sustainability-focused design, including solar panels, rainwater harvesting, and all-electric operations.

Abbott’s FreeStyle Libre portfolio can now support over 6 million people across 60+ countries, with this expansion helping to meet growing global demands. We are very grateful to be investing in Ireland's pharma and medical device infrastructure, and we look forward to helping more organisations optimize and advance their operations.